The Claim
In adults aged 40–75 with elevated LDL-C (70–190 mg/dL) and specific PPARG gene polymorphisms (rs10865710, rs7649970, rs1801282, rs3856806), daily supplementation with 2000 mg of omega-3 fatty acids for 90 days causes a 15.4% reduction in LDL-C and a 21.3% reduction in triglycerides, significantly greater than placebo, indicating that genetic variation in PPARG modulates lipid-lowering responses to omega-3 supplementation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For middle-aged and older adults with high 'bad' cholesterol and certain gene versions, taking 2000 mg of omega-3 fish oil every day for three months can lower their bad cholesterol and triglycerides more than a placebo — and their genes might make this effect stronger.
See the scientific wording
In adults aged 40–75 with elevated LDL-C (70–190 mg/dL) and specific PPARG gene polymorphisms (rs10865710, rs7649970, rs1801282, rs3856806), daily supplementation with 2000 mg of omega-3 fatty acids for 90 days causes a 15.4% reduction in LDL-C and a 21.3% reduction in triglycerides, significantly greater than placebo, indicating that genetic variation in PPARG modulates lipid-lowering responses to omega-3 supplementation.
What the research says
1 studyPeople with certain gene versions responded much better to omega-3 fish oil pills — their bad cholesterol and triglycerides dropped a lot — while people without those gene versions saw almost no change. This means your genes can affect how well omega-3s work for your heart.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.